1. P01.121 Optune treatment does not affect quality of life in treatment of high grade glioma compared to chemo-radiotherapy alone. (19th September 2018) Authors: Onken, J; Goerling, U; Heinrich, M; Guenes, S; Krex, D; Vajkoczy, P; Misch, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.121 Optune treatment does not affect quality of life in treatment of high grade glioma compared to chemo-radiotherapy alone. (19th September 2018) Authors: Onken, J; Goerling, U; Heinrich, M; Guenes, S; Krex, D; Vajkoczy, P; Misch, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P05.05.B A new IDH-wildtype glioma subtype characterized by highly diffuse growth pattern, distinct epigenetic profile and relatively favorable prognosis. (5th September 2022) Authors: Münch, A; Teichmann, D; Kuzman, P; Spille, D; Perez, E; May, S; Mueller, W; Kombos, T; Nazari-Dehkordi, S; Onken, J; Vajkoczy, P; Ntoulias, G; Paulus, W; Heppner, F; Koch, A; Capper, D; Kaul, D; Thomas, C; Schweizer, L Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗